Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

CorMedix (CRMD) Shares Outstanding (Weighted Average) (2016 - 2025)

CorMedix (CRMD) has disclosed Shares Outstanding (Weighted Average) for 14 consecutive years, with $72034.0 as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Weighted Average) rose 22.36% to $72034.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $72034.0 through Dec 2025, up 22.36% year-over-year, with the annual reading at $72034.0 for FY2025, 99.88% down from the prior year.
  • Shares Outstanding (Weighted Average) hit $72034.0 in Q4 2025 for CorMedix, down from $69.7 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $69.7 million in Q3 2025 to a low of $56455.0 in Q1 2022.
  • Historically, Shares Outstanding (Weighted Average) has averaged $39.5 million across 5 years, with a median of $40.3 million in 2022.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): tumbled 99.85% in 2022 and later soared 79134.5% in 2023.
  • Year by year, Shares Outstanding (Weighted Average) stood at $37.7 million in 2021, then increased by 6.92% to $40.3 million in 2022, then surged by 40.42% to $56.6 million in 2023, then crashed by 99.9% to $58872.0 in 2024, then increased by 22.36% to $72034.0 in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for CRMD at $72034.0 in Q4 2025, $69.7 million in Q3 2025, and $66.6 million in Q2 2025.